Lipella Pharmaceuticals Inc. (LIPO) Operating cash flow 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.0MFY2024 · since FY2021: -$989,271 → -$4.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$4.0M | -25.4% |
| FY2023 | -$3.2M | -72.0% |
| FY2022 | -$1.8M | -85.1% |
| FY2021 | -$989,271 | — |
Source: SEC XBRL filings · For reference only · Not investment advice